New deal
Gravity Gardens raises €2.6 million for a dry, chemical-free seed activation technology
09.09.2026
Our progress journal.
New deal
BVP and Bio&Tech Smart Capital join Healthplus.ai seed extension to bring AI infection risk prediction to surgical teams
03.09.2026
Portfolio
Vivalyx Omnisol® granted Breakthrough Medical Devices Status by the European Medicines Agency
27.08.2026
New deal
Silicozyme emerges from stealth, backed by BVP and LIOF, to make protein production simpler, lower-cost, and more scalable
16.07.2026
Portfolio
SHS Capital acquires majority stake in Basic Pharma
14.07.2026
Deep dive
From early stage innovation to system level change: our 2025 Impact Report
30.06.2026
Portfolio
Grassa wins Transition Award 2026 in the Food category
24.06.2026
Portfolio
Vivalyx wins Purpose and Impact Award at ODDO BHF Young Entrepreneurs Awards 2026
19.06.2026
Portfolio
Vertoro closes €17M Series B round to advance renewable oil platform to accelerate low-carbon fuels
17.06.2026
Deep dive
The three ways a health fund can decide what to back
15.06.2026
Portfolio
Honda uses Circularise to strengthen battery passport readiness ahead of 2027 EU requirements
10.06.2026
Portfolio
Matisse Pharmaceuticals receives FDA Fast Track Designation for isupartob sodium in sepsis
09.06.2026
Portfolio
Hy2Care selected for MedTech Innovator 2026 Accelerator Cohort
02.06.2026
Portfolio
Cell culture without animal serum: PL BioScience’s ELAREM validated in new Toxicology in Vitro study
01.06.2026
Portfolio
Stenting without X-rays: Nano4Imaging tools featured in new JACC study
21.05.2026
Portfolio
Matisse Pharmaceuticals receives FDA IND clearance for isupartob sodium
19.05.2026
Portfolio
Aliform wins MedTech World North America 2026 startup pitch competition
18.05.2026
Deep dive
How digital healthtech startups can gain investor trust: Pier interviewed by Luxinnovation
08.05.2026
Portfolio
niostem’s electrotrichogenic wearable device shows significant hair density gains in men with androgenetic alopecia
07.05.2026
Team
Roel van Wegberg promoted to Partner
23.04.2026
Deep dive
Impactful capital in practice: Roel & Carmel on a Delfin podcast on impact investing
13.04.2026
Deep dive
Investing in health is not impact investing
25.03.2026
Portfolio
Vivalyx announces First-in-Human use of Vivalyx Omnisol® in kidney transplant clinical trial
17.03.2026
Portfolio
Portfolio company Corporis Medical begins patient enrolment in clinical investigation of Laprixa
16.03.2026